Literature DB >> 34739545

Admission free-fatty acid level is a predictor of the mid-term worsening renal function in patients with ST-segment elevation myocardial infarction.

Masaomi Gohbara1,2, Noriaki Iwahashi3, Kozo Okada3, Yugo Minamimoto3, Yasushi Matsuzawa3, Masaaki Konishi4,3, Kiyoshi Hibi3, Masami Kosuge3, Toshiaki Ebina3,5, Teruyasu Sugano4, Toshiyuki Ishikawa4, Kouichi Tamura4, Kazuo Kimura4,3.   

Abstract

Whether free fatty acids (FFAs), which are generators of reactive oxygen species and substrates of cytotoxic lipid peroxidation products in proximal tubules of the kidney, can be a predictor of worsening renal function (WRF) is not fully elucidated. A total of 110 patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention within 24 h after symptom onset were included. The exclusion criteria were out-of-hospital cardiac arrest, vasospastic angina, hemodialysis, and/or lack of data. FFAs and serum cystatin C were measured on admission, and urinary liver-type fatty acid-binding protein (L-FABP) was measured 3 h after admission. WRF, defined as an increase in serum creatinine by ≥ 0.3 mg/dL for 2-year follow-up, was observed in 16 patients (15%). A multivariate logistic regression analysis (a stepwise algorithm) revealed that the FFA level was an independent predictor of WRF (P = 0.024). The FFA level was associated with WRF adjusted after serum cystatin C (odds ratio [OR]: 1.378 per 1 mEq/L, P = 0.017), L-FABP (OR: 1.370 per 1 mEq/L, P = 0.016), or the Mehran contrast-induced nephropathy (CIN) risk score (OR: 1.362 per 1 mEq/L, P = 0.021). The FFA level was inversely associated with the change in estimated glomerular filtration rate level for 2 years (R2 = 0.051, P = 0.018). The FFA level on admission was associated with the mid-term WRF in patients with STEMI.
© 2021. Springer Japan KK, part of Springer Nature.

Entities:  

Keywords:  Free fatty acid; Liver-type fatty acid-binding protein; ST-segment elevation myocardial infarction; Worsening renal function

Mesh:

Substances:

Year:  2021        PMID: 34739545     DOI: 10.1007/s00380-021-01982-0

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  2 in total

1.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

Authors:  Roxana Mehran; Eve D Aymong; Eugenia Nikolsky; Zoran Lasic; Ioannis Iakovou; Martin Fahy; Gary S Mintz; Alexandra J Lansky; Jeffrey W Moses; Gregg W Stone; Martin B Leon; George Dangas
Journal:  J Am Coll Cardiol       Date:  2004-10-06       Impact factor: 24.094

2.  Body composition and mortality in patients undergoing endovascular treatment for peripheral artery disease.

Authors:  Tadashi Itagaki; Soichiro Ebisawa; Kyuhachi Otagiri; Tamon Kato; Takashi Miura; Yusuke Kanzaki; Naoyuki Abe; Daisuke Yokota; Takashi Yanagisawa; Keisuke Senda; Yoshiteru Okina; Tadamasa Wakabayashi; Yushi Oyama; Kenichi Karube; Keisuke Machida; Takahiro Takeuchi; Tatsuya Saigusa; Hirohiko Motoki; Hiroshi Kitabayashi; Koichiro Kuwahara
Journal:  Heart Vessels       Date:  2021-06-07       Impact factor: 2.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.